{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/15/3311818/35550/fr/XBiotech-lance-un-essai-clinique-de-phase-II-visant-%C3%A0-%C3%A9valuer-le-vilamakitug-dans-le-traitement-de-la-spondylarthrite-axiale-active.html", "message": "News view counter 798969 successfully enlarged"}